BioNTech

News

Moderna sues Pfizer/BioNTech over COVID-19 vaccine tech

The rivalry between Moderna and Pfizer/BioNTech in commercialising their COVID-19 vaccines has now spilled over into the courts, in the form of a patent infringement lawsuit.

Views & Analysis

Closed up of sandglass or hourglass on background of book

Long COVID but short on treatment options

With COVID-19 vaccines and therapeutics developed in rapid time, Ben Hargreaves investigates why this has not been the case with the creation of a treatment for Long COVID.

News

Are rapid progress and patient engagement mutually exclusive in a COVID-19 world?

Pfizer, BioNTech seek US okay for Omicron BA.4/BA.5 booster

Pfizer and BioNTech have asked the FDA for emergency authorisation of an Omicron-targeted COVID-19 booster vaccine ahead of the planned autumn immunisation campaign in the US.

News

US government buys 66m doses of Moderna's Omicron booster

The Biden administration has

News

Pfizer takes COVID jab with 'enhanced' spike protein into ph...

Pfizer and BioNTech have started a mid-stage trial of a new version of the COVID-19 vaccine based on a version of the spike protein that they hope will offer greater and broader protection

News

BioNTech bites back after CureVac patent challenge

BioNTech has responded to a patent infringement lawsuit filed by fellow German biotech CureVac over its COVID-19 vaccine, saying it will "vigorously" defend itself.

Moderna sues Pfizer/BioNTech over COVID-19 vaccine tech

Long COVID but short on treatment options

Pfizer, BioNTech seek US okay for Omicron BA.4/BA.5 booster

US government buys 66m doses of Moderna's Omicron booster

Pfizer takes COVID jab with 'enhanced' spike protein into ph...

BioNTech bites back after CureVac patent challenge

CDMOs: Their crucial role and how to select one, with Sigma ...

How to meet your physicians where they are online

BioNTech

Editor's Picks